Viimane versioon :
Ravimite stabiilsus ja sobivus
Teretulemast Stabilise võrgulehele. Kui soovite kvartaliväljaannet, lisage oma e-posti aadress. Registreeri

Küsimuste ja kommentaaride korral palun kontakteeruda
Viited : 2728
Ingredient : 844
Ingrediendi farmakoloogiline grupp : 46
Lahuste stabiilsus : 6178
Stabiilsus segudes : 1219
Sobimatus : 12153
Kaubanduslik nimi : 4932
Uudised - Ingredient  
Vähiravimite Süsteravim Trastuzumab deruxtecan 17/11/2022
Vähiravimite Suukaudne lahus Vinorelbine 05/11/2022
Antibiootikum Süsteravim Cefradine 06/09/2022
Mitmesugune Süsteravim Ambroxol 06/09/2022
üldanesteetikum Süsteravim Esketamine 01/09/2022
Vähiravimite Süsteravim Melphalan captisol 01/09/2022
Antibiootikum Süsteravim Mezlocilline 01/09/2022
Vähiravimite Suukaudne lahus Ruxolitinib 28/06/2022
Mitmesugune Süsteravim Atosiban 02/06/2022
Mitmesugune Suukaudne lahus Epigallocatechin gallate 02/06/2022
Hüpoglükeemiline ravim Suukaudne lahus Sitagliptine phosphate 02/06/2022
Mitmesugune Kapsel Fludrocortisone acetate 05/05/2022
Anti dementsus Suukaudne lahus Pimavanserin 05/05/2022
Vähiravimite Suukaudne lahus Imatinib 03/05/2022
Vähiravimite Salv Erlotinib 03/05/2022
Seenevastane ravim Salv Voriconazole 03/05/2022
Elektrolüüt Süsteravim Magnesium chloride 14/03/2022
Immunosupressant Süsteravim Adalimumab 06/03/2022
Hormoonasendusravi Salv Gestrinone 04/03/2022
Põletikuvastane ravim Salv Nimesulide 04/03/2022
Uudised - Viited  
4717 Enhertu®- Résumé des caractéristiques du produit 18/11/2022
4711 Physicochemical stability of subcutaneous daratumumab (DARZALEX® 1800 mg injection solution) in plastic syringes over a period of 28 days stored refrigerated or at room temperature. GERPAC Congrès - octobre 2022 27/10/2022
4712 Développement de formulations buvables de vinorelbine à usage pédiatrique. GERPAC Congrès - octobre 2022 27/10/2022
4708 Study of the Stability of Sandoz Rituximab Biosimilar Rixathon®/Riximyo® When Subjected for up to 21 Days to Ambient Storage. Drugs R D 15/09/2022
4705 Stability of voriconazole 10 mg/mL ophthalmic solution during 90 days Pharmaceutical Technology in Hospital Pharmacy 12/09/2022
4702 Physicochemical stability of pemetrexed diarginine at 25 mg/mL in partially-used vials and at 3 and 12 mg/mL diluted in dextrose 5% or in sodium chloride 0.9% in polyolefin bags. EJOP 11/08/2022
4701 Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection. Pharm Dev Technol 10/08/2022
4700 Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics AS Kalceks 09/08/2022
4696 Physicochemical stability of 20 mg/mL amiodarone hydrochloride oral suspension in SyrSpend® SF PH4 (liquid) Pharmaceutical Technology in Hospital Pharmacy 20/07/2022
4697 Physicochemical stability of azacitidine suspensions at 25 mg/mL in polypropylene syringes stored under different conditions of storage. Pharmaceutical Technology in Hospital Pharmacy 20/07/2022
4698 Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs. Pharmaceutical Technology in Hospital Pharmacy 20/07/2022
4695 Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt. Int J Pharm Compound 15/07/2022
4694 Stability evaluation of compounded hydroxyurea 100 mg/mL oral liquids using a novel analytical method involving chemical derivatization. PlosOne 28/06/2022
4692 Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease. The Scientific World Journal 10/06/2022
4693 Compatibility and Stability of Ten Commonly Used Clinical Drugs in Pediatric Electrolyte Supplements Injection. Drug Design Dev Ther 10/06/2022
4691 Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine. Int J Pharm Compound 03/06/2022
4689 Captopril oral solution for pediatric use: formulation, stability study and palatability assessment in vivo. Braz J Pharm Sci 01/06/2022
4690 Stability of Compounded Digoxin Solution 0.05mg/mL for Injection. Hosp Pharm 01/06/2022
4686 Pertuzumab (Perjeta®) - Summary of Product Characteristics. Roche Products Ltd. 24/05/2022
4683 Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days J Pharm Pract and Res 05/05/2022
4681 An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding. Hosp Pharm 03/05/2022
4679 Stability of extemporaneously prepared sitagliptin phosphate solution. PlosOne 12/04/2022
4676 Assessing the stability of Sandoz rituximab biosimilar after exposure to out-of-fridge conditions for 21 days. EAHP Congress Vienna 05/04/2022
4677 Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags. EAHP Congress Vienna 05/04/2022
4675 Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations. Pharmaceuticals 18/03/2022
4673 Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases. Pharmaceutics 16/03/2022
4670 Stability and Formulation of Erlotinib in Skin Creams. Molecules 09/03/2022
4671 Voriconazole topical cream formulation: evidence for stability and antifungal activity. Int J Antimicrob Agents 09/03/2022
4669 Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration. Neuromodulation 03/03/2022
4666 Intravenous patient-controlled analgesia: in vitro stability profiles of mixtures containing fentanyl, hydromorphone, oxycodone, nefopam, ondansetron, and ramosetron. J Anal Sci Tech 28/02/2022

  Mentions Légales